Capital Flow Monitor · Sponsors · CIK 2078188
Atlas Venture Opportunity Fund Ill, L.P.
300 TECHNOLOGY SQUARE, CAMBRIDGE, MA, 02139 · 857-201-2700
Pooled Investment Fund / Venture Capital Fund · Limited Partnership· inc. DELAWARE true 2025
Fit score
—
Offering
$400.0M
Sold
$400.0M
% sold
100.0%
Investors
84
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-04 | D ·current | 506(b) | $400.0M | $400.0M | 100.0% | 84 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- N/A Atlas Venture Associates Opportunity III, L.P. — Executive Officer, Cambridge, MA
- N/A Atlas Venture Associates Opportunity III, LLC — Executive Officer, Cambridge, MA
- Bruce Booth — Executive Officer, Cambridge, MA
- Jason Rhodes — Executive Officer, Cambridge, MA
-
Kevin Bitterman — Executive Officer, Cambridge, MA
1 other raise
- Renasant Bio, Inc. $30.0M of $30.0M · 100.0%
-
Michael Gladstone — Executive Officer, Cambridge, MA
1 other raise
- Caldera Therapeutics, Inc. $37.5M of $37.5M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.